use, CII. Initial U.S. Approval: WARNING: ABUSE AND DEPENDENCE. See full Limitation of Use: VYVANSE is not indicated for weight loss. Use of placebo) in children, adolescents, and/or adults with ADHD were anorexia, anxiety.
Vyvanse (Lisdexamfetamine Dimesylate): First FDA-Approved Drug for the of adults with binge-eating disorder.4 This approval marks the expanded use of.
FDA approval history for Vyvanse (lisdexamfetamine dimesylate) used to treat ( CII) Now Approved in the US for Maintenance Treatment in Adults with ADHD.
The drug is the first FDA-approved medication to treat this condition that included adults with moderate-to-severe binge-eating disorder. it has high potential for abuse, with use potentially leading to dependence.
3 days ago Learn about the use of Vyvanse, which is an FDA-approved treatment for binge eating disorder and ADHD.